Abstract
No public abstract is available from the verified source records.
Jialong Liang, Jintao Zhou, Ziqi E, Feifan Ge, Mingfeng Zheng, Yong Ji
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline
10.1002/sctm.19-0037 · 2020
HSPB1 inhibits the endothelial-to-mesenchymal transition to suppress pulmonary fibrosis and lung tumorigenesis
10.1158/0008-5472.can-15-0952 · 2016
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
10.1038/s41467-020-14344-7 · 2020
Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis
2021
R213G polymorphism in SOD3 protects against bleomycin-induced inflammation and attenuates induction of proinflammatory pathways
10.1152/physiolgenomics.00053.2018 · 2018
Slicing tRNAs to boost functional ncRNA diversity
10.4161/rna.27177 · 2013
Targeting early pulmonary fibrosis with bone marrow mesenchymal stem cells and their derived exosomes: a comparative study of inhalation versus injection delivery in bleomycin-induced rat lung injury
10.1007/s00210-026-05750-7 · 2026
Engineering of stimulus-responsive pirfenidone liposomes for pulmonary delivery during treatment of idiopathic pulmonary fibrosis
2022
Bioinformatics analysis identifies potential ferroptosis key genes in the pathogenesis of pulmonary fibrosis
Confidence 0%
2021
An official american thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis
10.1165/rcmb.2017-0096st · 2017
Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases
10.1186/s13287-025-04318-1 · 2025
Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment
10.1038/s41392-025-02262-3 · 2025
tRNA and tsRNA: from heterogeneity to multifaceted regulators
10.3390/biom14101340 · 2024
tsRNA modifications: an emerging layer of biological regulation in disease
10.1016/j.jare.2024.09.010 · 2025
Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells
10.1080/15548627.2020.1717128 · 2020
Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: promises, problems and prospects
10.1002/med.22002 · 2024
Targeting growth factor and cytokine pathways to treat idiopathic pulmonary fibrosis
2022
Hydrogen peroxide preconditioning promotes protective effects of umbilical cord vein mesenchymal stem cells in experimental pulmonary fibrosis
10.15171/apb.2020.009 · 2020
Idiopathic pulmonary fibrosis: an update on pathogenesis
2021
Pulmonary fibrosis and exosomes: pathways to treatment
10.1007/s11033-025-10855-y · 2025
Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice
10.1111/resp.13928 · 2021
Sigmar1 ablation leads to lung pathological changes associated with pulmonary fibrosis, inflammation, and altered surfactant proteins levels
10.3389/fphys.2023.1118770 · 2023
ACSL4 Drives C5a/C5aR1-calcium-induced fibroblast-to-myofibroblast transition in a bleomycin-induced mouse model of pulmonary fibrosis
10.3390/biom15081106 · 2025
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis
2022
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
10.1172/jci143226 · 2021
Functions and mechanisms of UC-MSC-derived exosomal miR-486-5p in pulmonary fibrosis
2025
Mechanisms of mesenchymal stem/stromal cell function
10.1186/s13287-016-0363-7 · 2016
The long non-coding RNA PFI protects against pulmonary fibrosis by interacting with splicing regulator SRSF1
10.1038/s41418-021-00792-1 · 2021
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation
10.1016/j.apsb.2022.04.006 · 2022
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
10.1080/20013078.2018.1535750 · 2018
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
10.1002/jev2.12404 · 2024
Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
10.1186/s13045-021-01141-y · 2021
Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis
10.1080/10717544.2022.2057617 · 2022
Arctiin-encapsulated DSPE-PEG bubble-like nanoparticles inhibit alveolar epithelial type 2 cell senescence to alleviate pulmonary fibrosis via the p38/p53/p21 pathway
10.3389/fphar.2023.1141800 · 2023
Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment
10.1016/j.lfs.2019.116733 · 2019
Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routes
10.1186/s13287-022-02839-7 · 2022
Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis
2022
Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodeling
10.1186/s12931-018-0933-6 · 2018
Investigation of the pharmacological effect and mechanism of jinbei oral liquid in the treatment of idiopathic pulmonary fibrosis using network pharmacology and experimental validation
2022
Classification, function, and advances in tsRNA in non-neoplastic diseases
10.1038/s41419-023-06250-9 · 2023
Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury
10.1016/j.jconrel.2022.03.025 · doi-reference
Human umbilical cord mesenchymal stem cell-derived exosomes prevent and alleviate experimental pulmonary fibrosis by modulating the cytoskeleton of macrophages
10.1186/s13287-025-04646-2 · doi-reference
S-RBD-modified and miR-486-5p-engineered exosomes derived from mesenchymal stem cells suppress ferroptosis and alleviate radiation-induced lung injury and long-term pulmonary fibrosis
10.1186/s12951-024-02830-9 · doi-reference